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ABSTRACT
The human prolyl-4-hydroxylase domain (PHD)
proteins 1–3 are known as cellular oxygen sensors,
acting via the degradation of hypoxia-inducible
factor (HIF) a-subunits. PHD2 and PHD3 genes are
inducible by HIFs themselves, suggesting a negative
feedback loop that involves PHD abundance.
To identify novel regulators of the PHD2 gene, an
expression array of 704 transcription factors was
screened by a method that allows distinguishing
between HIF-dependent and HIF-independent
promoter regulation. Among others, the E-twenty
six transcription factor ETS translocation variant 4
(ETV4) was found to contribute to PHD2 gene ex-
pression particularly under hypoxic conditions.
Mechanistically, complex formation between ETV4
and HIF-1/2a was observed by mammalian
two-hybrid and fluorescence resonance energy
transfer analysis. HIF-1a domain mapping, CITED2
overexpression and factor inhibiting HIF depletion
experiments provided evidence for cooperation
between HIF-1a and p300/CBP in ETV4 binding.
Chromatin immunoprecipitation confirmed ETV4
and HIF-1a corecruitment to the PHD2 promoter.
Of 608 hypoxically induced transcripts found by
genome-wide expression profiling, 7.7% required
ETV4 for efficient hypoxic induction, suggesting a
broad role of ETV4 in hypoxic gene regulation.
Endogenous ETV4 highly correlated with PHD2,
HIF-1/2a and several established markers of tissue
hypoxia in 282 human breast cancer tissue samples,
corroborating a functional interplay between the
ETV4 and HIF pathways.
INTRODUCTION
Cellular adaptation to a shortage of oxygen is mainly
governed by transcriptional regulation. Hypoxia-inducible
factors (HIFs) are key players in the hypoxic cell and or-
chestrate the expression of hundreds of downstream target
genes, adapting the cellular metabolism to a low oxygen
environment (1). Heterodimeric HIFs consist of a tightly
O2-regulated a-subunit (HIF-1a, HIF-2a or HIF-3a) and
a constitutively expressed b-subunit (HIF-1b). At oxic
conditions, HIF a-subunits are continuously marked for
proteasomal degradation through hydroxylation of two
key prolyl-residues by prolyl-4-hydroxylase domain
(PHD) oxygen sensor proteins (2). PHD hydroxylation
activity fades as a direct function of oxygen, thus recipro-
cally controlling the nuclear accumulation of HIFas.
Stabilized HIF-complexes bind to a cis-acting HIF
binding site (HBS) conformed by a highly conserved
core 50-RCGTG-30 motif present in all direct target
genes (1,3,4). In analogy to destabilizing proline hydrox-
ylation, the transcriptional activity of HIF is tuned by
factor inhibiting HIF (FIH), which hydroxylates a
distinct asparagine residue within the HIF-a carboxy
terminus and consequently hinders its association with
the transcriptional 300-kilodalton coactivator protein
(p300) and cAMP response element-binding protein
(CREB) binding protein (CBP) (5–7).
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Among the three characterized HIF prolyl-4-
hydroxylases, PHD2 is widely accepted as the most
crucial isoform controlling basal activity of the HIF
pathway in oxic cells (8). Underlining its dominant role,
disruption of the Egln1 locus, encoding mouse PHD2,
results in prenatal lethality, while PHD1 and PHD3
knock out mice are born normally (9). Broad-spectrum
conditional deletions of all three PHDs in mice revealed
a global hyperproliferative vascular phenotype uniquely
when targeting PHD2, demonstrating an absolute require-
ment for PHD2, which is not conﬁned to embryonic
development (10). Accordingly, PHD2 abundance is con-
sidered as a critical factor in tumor angiogenesis, although
divergent roles of stromal and tumor cell-derived
PHD2 have been discussed (11–13). As PHD2 protein is
strikingly stable and the de novo translated enzyme outlasts
a period of transient hypoxia by more than 48h, transcrip-
tional regulation of the PHD2 locus must be considered as
the main process deﬁning cellular levels of PHD2 (14,15).
Expression of PHD2 itself is delicately inﬂuenced by HIF
transcriptional activity, forming a negative feedback loop
which facilitates dynamic oxygen sensing (16–18).
To identify upstream regulatory pathways affecting
PHD2 gene expression in an unbiased system, we de-
veloped a screening approach that allows the identiﬁcation
of transcriptional interactions with DNA-bound HIF
complexes and HIF-independent promoter regulation at
the same time. The herein described synthetic transactiva-
tion screening led to the identiﬁcation of several members
of the E-twenty six (ETS) and FBJ murine osteosarcoma
viral oncogene homolog (FOS) families of transcription
factors as novel activators of the human PHD2 promoter
(P2P). Among those, ETS translocation variant 4 (ETV4;
also known as E1A enhancer binding protein, E1AF, or
polyoma-enhancing activator 3, PEA3), was found to be
a potent coactivator of HIF-1-dependent transcription.
MATERIALS AND METHODS
Cell culture
Human HeLa cervix carcinoma and U2OS osteosarcoma
cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Sigma). Human PC3 prostate cancer cells were
cultured in Roswell Park Memorial Institute medium
(RPMI-1640, Sigma). Media were supplemented with
10% fetal calf serum (FCS) and antibiotics (penicillin
50 IU/ml and streptomycin 100 mg/ml; Gibco-BRL).
Hypoxic cell culture was carried out at 0.2% O2 (if not
indicated differently) using a gas-controlled InvivO2 400
workstation (Ruskinn Technologies). Transfections were
performed using polyethyleneimine (PEI; Polysciences) as
described earlier (17).
P2P constructs
P2P constructs containing the wild-type and mutant HBS
in the pGL3basic luciferase vector (Promega) were
generated in earlier work (16). Serial 50-truncations of
P2P and a start codon fusion to the luciferase open
reading frame (ORF) were used for both promoter
versions using standard cloning techniques. Within the
scope of the screening approach, the ﬁreﬂy reporter gene
of pGL-P2P(607/+3) variants was replaced with the
renilla luciferase ORF cloned into NcoI and XbaI sites.
Transfection and synthetic transactivation screening
Reverse transfection (19) and screening were carried out
using an arrayed expression library containing 704 tran-
scriptionally relevant human full-length cDNAs from the
Origene collection (FTCW 19603, GFC-transfection array
in a 96-well format). An annotated list of all genes covered
by this array is provided online by the manufacturer.
Dried DNA (100 ng) of a distinct expression construct
spotted per well was reconstituted at room temperature
with 20 ml of serum-free medium containing a mixture of
pGL-P2P(607/+3) HBSwt ﬁreﬂy and pGL-P2P(607/
+3) HBSmut renilla reporter plasmids (100 ng DNA/
each). Subsequently, 20 ml of diluted TransIT-LT1 trans-
fection reagent (3:1, mg DNA/ ml TransIT-LT1; Mirus Bio
LLC) was added and complex formation was allowed for
30min at room temperature before 60 ml of a cell suspen-
sion containing 1 104 U2OS cells in DMEM supple-
mented with 10% FCS were plated in each well. Plates
were incubated at 20% O2 for 24 h before being subjected
to the screening conditions of 0.2% O2 for an additional
24 h. Cultures were lysed in 20 ml of passive lysis buffer
(Promega) and luminescence was immediately analyzed
with a microplate luminometer (Berthold) using a
standard dual luciferase reporter assay system
(Promega). Luciferase activities were normalized to
the median calculated individually for each plate and
luminescence source and expressed as induction factors
(IF) according to the equation IF ¼ Nimediani, with Ni
indicating individual luciferase activity value of each well
of plate i and mediani indicating median of luciferase
activities of all 96-wells on plate i. To compare the distri-
bution of replicate assays a standard z-score evaluation
was performed following the equation Z ¼ ðNi XiÞi , withXi, plate mean of respective luminescence values and i,
standard deviation (SD) of plate mean of luminescence
values.
Reporter gene assays and mammalian two-hybrid analyses
Construction of pGLTfHRE wt and pGLTfHRE mut
reporter plasmids carrying a hypoxia-responsive
enhancer element derived from the human Transferrin
gene was described previously (20). Transfections for
standard reporter gene experiments were carried out on
100mm culture plates essentially as described earlier
(17). In brief, U2OS cells were cotransfected with 3 mg
reporter plasmid or a mix of 1.5 mg reporter and 1.5 mg
expression plasmids, respectively. Transfection efﬁciency
was controlled by cotransfection of 20 ng pRLSV40
renilla luciferase reporter vector (Promega). RNA-
interference (RNAi) mediated knock down of HIF-1a,
FIH-1 or p300 was achieved by transiently transfecting
once (HIF-1a, p300) or twice (FIH-1) U2OS cells with
100 nM stealth RNAi duplexes (HIF-1a, 50-caggacaguac
aggaugcuugccaa-30; FIH-1, 50-gaaacauugagaagaugcuugga
ga-30; p300, 50-ggauucgucugugauggcuguuuaa-30; control,
50-gcuccggagaacuaccagaguauua-30; sense strands) using
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Lipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen). Combined knock down and
reporter gene analyses were performed by sequentially
transfecting cells with stealth RNAi duplexes 24 h before
subjecting them to polyethyleneimine (PEI)-mediated
DNA transfection.
Mammalian two-hybrid analyses were performed using
the mammalian Matchmaker system (Clontech) as
described previously (14). Expression vectors of HIF-1a
NAD and carboxy-terminal activation domain (CAD)
fused to Gal4 DBD (21) were a kind gift of Dr Sang
(Drexel University, Philadelphia, PA, USA). U2OS cells
were transiently cotransfected with 1.5mg of Gal4 DBD
and 1.5mg of VP16 AD fusion protein vectors together
with 500 ng of ﬁreﬂy luciferase reporter vector
pGRE5xE1b and 20 ng of pRL-SV40. Total transfected
DNA amounts were equalized in each experiment using
the corresponding empty vector. Luciferase reporter gene
activities were determined using the dual-luciferase
reporter assay system (Promega).
Fluorescence resonance energy transfer
The full-length ORF of human ETV4 was cloned into
pENTR4 and subsequently recombined with pECFP-C1-
DEST (15) to obtain the expression vector for a cyan
ﬂuorescent ETV4 fusion protein. U2OS cells were transi-
ently transfected with the pECFP-ETV4 and pEYFP-
HIF1 or pEYFP-HIF2 plasmids as recently described
(22). Fluorescence resonance energy transfer (FRET)
was monitored under normoxic or hypoxic conditions
(1% O2 for 4 h) 24–48 h post-transfection.
Protein extraction and immunoblot analysis
Cells were washed twice and scraped into ice-cold
phosphate-buffered saline. Soluble cellular protein was ex-
tracted with a high salt extraction buffer containing 0.4M
NaCl, 0.1% Nonidet P-40, 10mM Tris–HCl (pH 8.0),
1mM EDTA, 1mM dithiothreitol, 1mM phenylmethy-
lsulfonyl ﬂuoride and 1 protease inhibitor cocktail
(Sigma). Protein concentrations were determined by the
Bradford method and 50–80mg of cellular protein were
subjected to immunoblot analysis using the following
antibodies: mouse monoclonal antibody (mAb), anti-
human HIF-1a (clone 54/HIF-1a; BD Transduction
Laboratories), mAb anti-ETV4 [PEA3 (16); Santa Cruz
Biotechnology], rabbit anti-ETV4 (sdix20580002; Novus
Biologicals), rabbit anti-human PHD2 (NB100-137;
Novus Biologicals), mAb anti-FIH-1 (NBP1-30333;
Novus Biologicals), mAb anti-p300 (554215; BD
Pharmingen) and mAb anti-b-actin (clone AC-74;
Sigma). Primary antibodies were detected with respective
polyclonal anti-mouse or anti-rabbit sera conjugated to
horseradish peroxidase (Pierce). Chemiluminescence
signals were developed using Supersignal West Dura sub-
strate (Pierce) and images were acquired with a digital
light imaging system (LAS 4000; Fuji).
mRNA quantiﬁcation
Complementary DNA was generated by reverse transcrip-
tion (RT) of 1–5 mg of total RNA using AfﬁnityScript
reverse transcriptase (Agilent). Transcript levels were
determined by real-time quantitative (q) polymerase
chain reaction (PCR) using a SybrGreen qPCR reagent
kit (Sigma) in combination with the MX3000P light
cycler (Agilent). All RT-qPCR data are presented as
ratios relative to ribosomal protein L28 mRNA values.
Primer sets for human PHD2, CA9 and L28 have been
described earlier (17,23).
TMA analysis
Clinicopathological characterization and immunohis-
tochemical analyses of selected components of the
HIF-pathway using a tissue microarray (TMA) consisting
of 282 invasive breast cancer cases diagnosed at the
Institute of Surgical Pathology (University Hospital,
Zu¨rich, Switzerland) have been described recently (13).
Sections of the same TMA were stained with a rabbit
polyclonal anti-ETV4 antibody (HPA005768, Sigma) in
a 1:100 dilution using an automated immunohisto-
chemistry platform (Ventana BenchMark, Roche). An
immunoreactive score for ETV4 staining was calculated
by multiplication of staining intensity (graded between 0
and 3) and the percentage of positive cells (graded between
0 and 4 with 0, nil; 1, <10%; 2, 10–50%; 3, 51–80%; 4,
>80%) as quantiﬁed by a senior pathologist (G.K.).
Nonparametric correlations between ETV4 expression
and HIF-1/2a or HIF target genes were analyzed by
calculating Spearman’s rank correlation coefﬁcient using
predictive analysis software (IBM SPSS Statistics 18).
Short hairpin RNA constructs and lentiviral infections
Expression vectors encoding short hairpin RNA (shRNA)
sequences targeting human ETV4 and a noncoding
control driven by the U6 promoter in a pLKO.1-puro
plasmid were purchased from Sigma. Viral particles were
produced in HEK293T cells using the ViraPower lentiviral
expression system according to the manufacturer’s in-
structions (Invitrogen). Infected PC3 cells were cultured
in RPMI-1640 supplemented with 0.5 mg/ml puromycin.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) assays from
parental PC3 cells exposed to 20% or 0.2% O2 for 4
and 24 h were performed essentially as described previ-
ously (24). The following antibodies were used for immu-
noprecipitation: rabbit anti-HIF-1a (ab2185; Abcam) and
rabbit anti-ETV4 (sdix20580002; Novus Biologicals).
Rabbit serum (011-000-001; Jackson ImmunoResearch)
served as unspeciﬁc control. Enrichment of P2P chromatin
was determined by PCR using the following oligonucleo-
tides: PHD2 forward 50-gtatgccctgcgctcctc-30, reverse
50-gctgagagaatagggcctgtg-30.
Gene array analysis
Total RNA was extracted from pools of shRNA express-
ing PC3 clones with RNeasy (Qiagen). RNA integrity was
evaluated using the Agilent 2100 Bioanalyzer. Genome-
wide RNA levels were quantiﬁed using the human gene
expression ShurePrint GE3 (8 60K) microarray accord-
ing to the manufacturer’s instructions (Agilent). All data
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were deposited in NCBI’s Gene Expression Omnibus
(GEO) and are publicly accessible through GEO accession
number GSE32385 (http://www.ncbi.nlm.nih.gov/geo/).
Statistical analysis
If not otherwise indicated, results are presented as mean
values± standard error of the mean of at least three in-
dependent experiments. Column statistics applying paired
Student’s t-tests were calculated using GraphPad Prism
version 4.0 (GraphPad Software).
RESULTS
A single HBS is sufﬁcient for hypoxic induction
of the human P2P but dispensable for basal
promoter activity
Previously, we have reported on a functional, single
HIF-binding site located in the 50-regulatory region of
the human PHD2 gene (16). Using a series of 50-truncated
luciferase reporter genes (schematically depicted in
Figure 1A), the minimal hypoxia-responsive region of
the P2P was further mapped to an element spanning nu-
cleotides 424 to+3 relative to the translational start site.
While pGL-P2P(424/+3) still revealed high hypoxic
inducibility when transiently transfected into U2OS or
HeLa cells, normoxic promoter activity of this region
was largely lost when compared with the longer promoter
variants, regardless of whether the HBS was wild-type or
mutant (Figure 1B). Elongation of the promoter by at
least 183 nts [construct pGL-P2P(607/+3)] showed
robust normoxic activity in both cell lines (Figure 1B).
As basal induction of HBS-lacking constructs was
observed between nucleotides 424 and 607 without
any further effects upstream, the existence of transcrip-
tionally active elements required for oxic expression of
the PHD2 gene in this particular region is suggested
(Figure 1B). Of note, the fold of hypoxic activation of
Figure 1. Identiﬁcation of the minimal human P2P. (A) Schematic representation of P2P 50-truncations and their cloning strategy as used in this
study. The translational start site is designated ‘+1’. (B) Regulatory DNA regions of the human PHD2 gene were cloned into luciferase reporter
vectors that were transiently transfected into human U2OS osteosarcoma cells. One day after transfection, cells were incubated for 24 h at 20 or 0.2%
O2. Hypoxic IF (mean values±SD) of relative luciferase activities were calculated from three independent experiments performed in triplicates.
Mutation of a single HBS (black rectangles in A) completely abrogated hypoxic inducibility of all constructs. (C) HeLa and U2OS cells were
incubated at 20 or 0.2% O2 for 4–24 h and protein levels of HIF-1a, PHD2 and b-actin were analyzed by immunoblotting. Total RNA was isolated
from cultures treated as in (B) and mRNA levels of PHD2 and CA9 were determined by RT-qPCR. Transcript levels of CA9 served as positive
control to conﬁrm continuous hypoxic responses. Gene expression levels were expressed in relation to ribosomal L28 mRNA (rel. levels) calculated
from three independent experiments (±SD).
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pGL-P2P(607/+3) resembled the oxygen-dependent IF
of endogenous PHD2 mRNA and protein in both cell
lines (Figure 1C).
A differential screening approach to identify site-speciﬁc
transcription factor interplay
Multiplexed transfection of ﬁreﬂy and renilla reporter
genes controlled by either wild-type or HBS-mutant
P2Ps, respectively, allows to classify any reporter-
modulating event as HIF-dependent or self-sufﬁcient.
Moreover, the dual reporter system provides a read-out
that permits to screen under HIF-stabilizing conditions
(e.g. hypoxia) while simultaneously assessing the
noninduced background levels (simulated ‘normoxia’) in
the very same cells, thereby reducing intra-assay
variabilities and screening complexity. Nucleotides 607
to+3 of the P2P containing either the wild-type or mutant
HBS were used to drive transcription of ﬁreﬂy or renilla
luciferase cDNAs, respectively. The two luciferase
reporter genes showed identical hypoxic responses in the
respective reporter vectors (Figure 2A). As a proof of
principle, this system was tested by coexpressing mIpas,
encoding an inhibitory isoform of HIF-a (25), with the
two reporter plasmids as described above. Indeed, a
marked downregulation of hypoxic ﬁreﬂy versus renilla
luciferase activity was observed when compared with
cotransfection with the empty vector or an unrelated tran-
scription factor (mHes-1). As expected (17), forced expres-
sion of PHD2 or PHD3 strongly attenuated the hypoxic
activation of the reporter system, conﬁrming that also
post-translational mechanisms impairing the activation
state of the HIF-pathway can be assessed by this
method (Figure 2B).
Members of the FOS and ETS transcription factor
families transactivate the human P2P
An array of 704 cDNA expression vectors representing
all commonly known transcription factor families was
screened using the HBS-speciﬁc synthetic transactivation
readout. Possible HIF coregulators alter ﬁreﬂy but not
renilla luciferase expression, whereas HIF-independent
factors interfere with both reporters (schematically
depicted in Figure 2C). A work ﬂow of the transfection
and screening procedure is given in Figure 2D. Two inde-
pendent screens were performed and reproducibility was
visualized by plotting z-scores (Figure 2E). Solid correl-
ations were observed for the vast majority of the
coexpressed transcription factors, conﬁrming that no sig-
niﬁcant deviation between the two experiments occurred.
Reporter gene inductions by each coexpressed transcrip-
tion factor were calculated as multiples of the respective
96-well plate median individually for ﬁreﬂy and renilla
activities, averaged over the two experiments, and
ranked according to the IF of the HBS-mutant renilla
reporter (Figure 2F). The cut-off was deﬁned as an
increase in luciferase activity by a factor of at least 2,
tolerating a deviation of 0.05. Factors that showed a re-
producible increase in either ﬁreﬂy luminescence
(Supplementary Table S1A) or ﬁreﬂy and renilla lumines-
cence together (Supplementary Table S1B) were
considered as leads. Underlining the validity of this
approach, the only known transcriptional activator of
PHD2 expression, namely HIF-1a, was among the
cDNAs identiﬁed (Figure 2E and F). For reevaluation,
the cDNAs of 43 leads were retrieved and partially
sequenced to verify their identities. Seven of these
cDNAs, namely ETS-variant 4 (ETV4), Spi-C transcrip-
tion factor (SPIC), ETS homologous factor (EHF), the
proto-oncogenes JUN and FOSB, v-crk sarcoma virus
CT10 oncogene homolog (CRK) and Jumonji
domain-containing protein 2A resulted in a reproducible
HBS-dependent regulation of the P2P. Most of these
factors can be attributed to two major groups: the ETS
(ETV4, EHF and SPIC) and the FOS (JUN and FOSB)
families.
ETV4 activates PHD2 and transferrin promoters
synergistically with HIF-1
Expression vectors of the seven newly identiﬁed factors
were cotransfected together with pGL-P2P(607/+3)
HBS wild-type or mutant reporter genes, cloned into iden-
tical backbones to exclude false positive effects, which
may have resulted from the two different luciferase
cDNAs in the original screen. In the presence of a func-
tional HBS, coexpression of ETV4 resulted in a striking
super-induction of the P2P under hypoxic conditions only
(Figure 3A, left panel), which was fully lost with the
mutant construct (Figure 3A, right panel). As ETV4 was
the strongest hit identiﬁed, subsequent work focused on
the role of this transcription factor as a putative
transactivator of PHD2. Of note, the P2P region used in
this screen lacks a consensus 50-A/CGGAAGT-30 ETV4
binding site (26). Thus, direct binding of ETV4 to P2P
appears unlikely, although not fully excluded regarding
the small residual stimulation of constitutive P2P
activity following HBS mutation. However, the complete
lack of hypoxic P2P stimulation by ETV4 suggests that
HIF-1 might actually recruit ETV4 to enhance hypoxic
induction. Accordingly, knock down of HIF-1a by RNA
interference in U2OS cells abrogated hypoxia and
ETV4-mediated induction of the wild-type P2P (Figure
3B, right panel), while an unrelated control siRNA had
no effect (Figure 3B, left panel). A heterologous reporter
construct driven by the minimal SV40 promoter in con-
junction with either a wild-type (Figure 3C, left panel) or
mutant (Figure 3C, right panel) hypoxia response element
derived from the human Transferrin gene (20)
recapitulated the strong hypoxic superinduction by ex-
ogenous ETV4, proposing a more general model of syn-
ergistic interaction between ETV4 and HIF-1. In line with
our screening data, overexpressed ETV4 signiﬁcantly
upregulated endogenous PHD2 mRNA and protein
levels in hypoxic U2OS cells, while PHD1 mRNA levels
remained unaffected (Figure 3D and E).
ETV4 interaction with the carboxy-terminal
transactivation domain of HIF-1a depends on
corecruitment of p300
Intrigued by the HIF-dependent ETV4 effects, we aimed
for the characterization of a putative physical interaction
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Figure 2. Synthetic transactivation screening allows to discriminate HBS-dependent and independent promoter activation. (A) P2P(607/+3) driven
ﬁreﬂy (blue) and renilla (red) luciferase reporter genes transfected into U2OS cells show similar hypoxic activation (0.2% O2 for 24 h, black bars)
when compared with normoxic (20% O2, open bars) cultures. HBS mutation completely abrogated hypoxic induction of both constructs. (B)
Coexpression of transcription factors (mIpas, mHes-1) or PHD enzymes with P2P(607/+3)wt HBS driven ﬁreﬂy and P2P(607/+3)mut
HBS-driven renilla luciferase reporters, respectively. Dual luciferase activities were determined after 24 h of hypoxic exposure (0.2% O2) and
expressed as relative luciferase activity normalized to controls receiving the empty expression vector. (C) Schematic overview of the
P2P-luciferase constructs used for synthetic transactivation screening. Expected readouts for HBS-dependent (ﬁreﬂy reporter activation only, blue
circle) and independent reporter gene activation (simultaneous activation of ﬁreﬂy and renilla reporter genes indicated by blue and red circles,
respectively) are illustrated by a cross table. (D) Workﬂow of synthetic transactivation screening analyzing a commercial transcription factor
expression library. (E) Z-scores of two independent screening experiments were plotted for both reporters. Thresholds for z> 2 are indicated by
dotted lines. (F) Paired values for individual coexpressed cDNAs for ﬁreﬂy (blue) and renilla (red) read-outs are depicted. A fold of induction >2 was
considered as lead for a re-screening. Positions of HIF-1a and seven new transcription factors positively re-evaluated at a secondary screening level
are indicated. Data are given as the mean of two independent screening experiments. For calculations and full gene names refer to the text.
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Figure 3. Hypoxic transactivation of the P2P by ETV4 requires HIF-1a activity. (A) Standard dual luciferase reporter gene assays of seven
reevaluated hits from the transcription factor overexpression array. Wild-type (left panel) or HBS mutant (right panel) P2P regions controlling
ﬁreﬂy luciferase reporter plasmids were cotransfected into U2OS cells together with expression constructs of the aforementioned factors. Transfection
of an empty expression vector (empty) served as negative control and differences in transfection efﬁciency were controlled by cotransfecting SV40
promoter driven renilla luciferase. Cells were cultured at 20% or 0.2% oxygen for 24 h before dual luciferase activities were determined. (B) Transient
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(continued)
between ETV4 and HIF-1a. Using a mammalian two-
hybrid system, expression plasmids encoding for ETV4
fused to the activation domain (AD) of viral protein 16
(VP16-ETV4) were cotransfected with HIF-1a oxygen
regulatory domains (21,27) fused to a Gal4-DNA
binding domain (DBD; Figure 4A). Due to its intrinsic
transactivation activity, constructs containing the CAD
of HIF-1a [amino acids 775-826 (27)] were sufﬁcient to ac-
tivate the Gal4-responsive promoter (Figure 4B).
Coexpression of ETV4 strikingly superinduced
GH1a740-826 and GH1a786-826, particularly under
hypoxic conditions, suggesting that HIF-1a CAD and
ETV4 cooperate to transactivate target genes (Figure
4B). ETV4 effects on the aminoterminal activation
domain (27) (NAD; HIF-1a amino acids 549-582) were
negligible. Both, HIF-1a and ETV4 have been
demonstrated to interact with the ubiquitous transcrip-
tional coactivators p300/CBP (28,29). To address the
question whether the two factors directly interact or
whether a ternary complex between HIF-1, p300/CBP
and ETV4 is formed (schematically depicted in Figure
4C), binding of HIF-1a CAD to p300 was disrupted by
forced overexpression of CBP/p300-interacting trans-
activator 2 (CITED2), known to negatively regulate HIF
function (30). Structural analyses revealed that CITED2
and HIF-1a share an overlapping binding interface in the
p300 cysteine–histidine-rich 1 (CH1) domain and compe-
tition assays showed a 33-fold higher afﬁnity of CITED2
for binding to p300 CH1 than a corresponding HIF-1a
CAD peptide, indicating that CITED2 is a dominant in-
hibitor of HIF-1a:p300/CBP complex formation (31).
HIF-1a CAD:ETV4 interplay was totally abrogated
by CITED2 in mammalian two-hybrid experiments
(Figure 4D), underscoring the assumption that ETV4
coactivation of HIF-1 requires functional interaction of
the latter with p300/CBP.
While transient knock down of p300 slightly reduced
the intrinsic transactivation activity of GH1a786-826 in
mammalian two-hybrid experiments, robust superinduct-
ion of this construct occurred when VP16-ETV4 was
cotransfected, irrespective of the presence of p300
(Figure 4E). Thus, we assume that both p300 and CBP
can function as bridging molecules for HIF-1a CAD:
ETV4 interplay. Underlining the essential requirement of
p300/CBP for HIF-1a:ETV4 interaction, normoxic trans-
activation activity of cotransfected GH1a786-826 and
VP16-ETV4 was similar to hypoxic activation levels in
U2OS cells transiently depleted of FIH (Figure 4F). FIH
has been described previously as oxygen-dependent
negative regulator of HIF-a:p300/CBP interaction (7).
ChIP experiments using either anti-HIF-1a or anti-ETV4
antibodies revealed oxygen-dependent enrichment of the
HRE-containing PHD2 (EGLN1) promoter region in both
precipitations (Figure 4G), providing further evidence
for corecruitment of the two transcription factors to the
endogenous PHD2 locus.
Both HIF-a isoforms are capable of forming a complex
with ETV4
Fluorescence resonance energy transfer (FRET) analyses
of coexpressed ETV4 and HIF-1a marked with cyan or
yellow ﬂuorescent protein tags (CFP and YFP, respective-
ly) resulted in a robust energy transfer between both
factors. Similar FRET efﬁciencies were observed when
YFP-labeled HIF-2a was used together with CFP-ETV4
(Figure 5A and B). The intracellular distance of the two
nuclear proteins was calculated to be 5.6–5.7 nm and did
not differ in oxygenated or hypoxic cells, which might
be explained by saturation of the HIF-a degradation
pathways by exogenous overexpression of the transcrip-
tion factors. Notably, efﬁcient energy transfer between
HIF-1a and p300 at ambient oxygen tensions has been
reported previously (32).
A broad role for ETV4 in hypoxic gene expression
Recent work reported high ETV4 expression levels in the
human prostate cancer cell line PC3 that lacks the consti-
tutive photomorphogenic protein COP1 acting as E3 ubi-
quitin ligase for a variety of ETS proteins (33,34). As
endogenous ETV4 expression levels in U2OS cells were
close to the detection limit, the PC3 cell model was
chosen to study the involvement of ETV4 in the hypoxic
response by applying a genome-wide expression array
screening. PC3 cells lentivirally infected with shRNA ex-
pression constructs targeting ETV4 (shETV4) revealed a
robust knock down of mRNA and protein levels, while a
nontarget control shRNA (shNTC) did not affect ETV4
expression (Figure 6A and B). ETV4 depleted PC3 cells
showed robustly reduced mRNA levels of the known
ETV4 target gene cyclooxygenase-2 (COX2) (29,35), con-
ﬁrming loss of ETV4 function in these cells (Figure 6B).
Total RNA was isolated from PC3 shETV4 and shNTC
control cells exposed to 20 or 0.2% oxygen for 24 h and
samples from three independent experiments were labelled
for microarray analysis. When compared with normoxic
control cells, 977 mRNAs and large intergenic noncoding
Figure 3. Continued
RNAi mediated knock down of HIF-1a fully abrogated hypoxic activation of the P2P by ETV4. U2OS cells were transiently transfected with siRNA
oligonucleotides targeting HIF-1a (siHIF1a, right panel) or a control sequence having no human target (siControl, left panel). Reporter gene
experiments using the P2P reporter construct with only wild-type HBS were performed as described in (A). The inset shows an immunoblot
conﬁrming the robust knock down of HIF-1a in U2OS cells. (C) ETV4 and HIF-1 synergism in hypoxic gene activation is not restricted to the
P2P. A heterologous hypoxia responsive reporter gene containing two functional HBS from the human Transferrin hypoxia response element
(pGL-TfHRE wt) was tested in luciferase reporter assays as described in (A). Mutation of both HBS (pGL-TfHRE mut) caused an abrogation
of the signal as seen in (A). (D and E) Forced expression of ETV4 in U2OS cells upregulates endogenous PHD2 protein and transcript
levels. (D) Whole cell lysates were prepared from cells exposed for 16 h to 20 or 0.2% oxygen and analyzed for HIF-1a, ETV4, PHD2 and
b-actin levels by immunoblotting. (E) Total RNA was extracted of similarly treated cells and mRNA levels of PHD1, PHD2 and L28 were quantiﬁed
by RT-qPCR. Data are shown in relation to ribosomal L28 mRNA (rel. levels) calculated from three independent experiments (**P< 0.01, paired
Student’s t-test).
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Figure 4. Transcriptional cooperation between ETV4 and HIF-1 is disrupted by CITED2. (A) Schematic representation of HIF-1a and ETV4
domain structure and fusion constructs used in mammalian two-hybrid assays. PAS, PER-ARNT-SIM; bHLH, basic helix–loop–helix domain;
ODD, oxygen-dependent degradation domain; NRR, negative regulatory region; NAD and CAD, amino-carboxy-terminal activation domain and
CADs, respectively. A GAL4-DBD was fused to regions encompassing the HIF-1a NAD and CAD. Full-length ETV4 bearing two activation
domains (AD, acidic domain; Ct, carboxy-terminal tail) ﬂanking a central ETS domain was fused to a VP16 activation domain (VP16-AD). Numbers
indicate the amino acids present in the respective constructs. (B) U2OS cells were cotransfected with a Gal4-responsive reporter plasmid and
Gal4-HIF-1a (GH1a) constructs alone or in combination with VP16-ETV4. The GH1a fusion constructs are speciﬁed by the aminoterminal
starting amino acid of the truncated HIF-1a regions (530, 740 and 786, respectively). Following transfection, cells were evenly split and incubated
at 20 or 0.2% O2 before luciferase activities were determined 24 h later. Noninteracting Gal4 DBD-p53 and VP16-AD-CP1 served as negative control
(neg. ctrl.), while the interactions between Gal4 DBD-PHD2 and VP16-AD-HIF-2a(ODD) or VP16-AD-FKBP38 were used as positive controls
(pos. ctrl. 1 and pos. ctrl. 2, respectively). (C) Scheme of the potential interactions between HIF-1, p300/CBP and ETV4 as assessed by mammalian
two-hybrid assays. Both CITED2 and FIH can block the interaction between HIF-1a and p300/CBP. (D) Cotransfection of the indicated amounts of
a CITED2 expression construct together with the mammalian two-hybrid expression vectors followed by hypoxic exposure and luciferase activity
determination as described for (B). (E) Cotransfection of siRNA directed against p300 together with the mammalian two-hybrid expression vectors
followed by hypoxic exposure and luciferase activity determination as described for (B). The p300 knock down efﬁciency of different siP300
oligonucleotides was analyzed by immunoblotting (upper panel) and siP300#1 was chosen for further experiments. (F) Cotransfection of siRNA
directed against FIH together with the mammalian two-hybrid expression vectors followed by hypoxic exposure and luciferase activity determination
as described for (B). The efﬁciency of the siFIH mediated FIH knock down was conﬁrmed by immunoblotting as shown in the inset. (G) ChIP of
normoxic or hypoxic PC3 cells using antibodies directed against HIF-1a or ETV4, or control serum. The amount of coprecipitated chromatin derived
from the human P2P region (encoded by EGLN1) containing the HBS was determined by PCR followed by agarose gel electrophoresis.
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RNAs (lincRNAs) were more than twofold down-
regulated (P< 0.05) in normoxic PC3 cells lacking ETV4
(Figure 6C; green). Hypoxia alone upregulated 608
mRNAs/lincRNAs by more than twofold (P< 0.05;
Figure 6C; red). Interestingly, 450 mRNAs/lincRNAs
showed a more than twofold reduction (P< 0.05) of the
hypoxic expression levels in cells lacking ETV4 when
compared with hypoxic control cells (Figure 6C; blue),
out of which a group of 47 mRNAs/lincRNAs was
found to be simultaneously hypoxia-inducible. Individual
expression levels of these 47 transcripts centered on the
mean of the three normoxic control samples (PC3
shNTC) are depicted in a heatmap in Figure 6D. Array
data were validated by RT-qPCR of four randomly
chosen transcripts (Figure 6E).
HIF target genes divide into two groups, either ETV4
coactivated or independent
Because hypoxically upregulated gene sets are highly
variable between different cellular models, we next
focused on a predeﬁned gene set of 61 hypoxia-inducible
transcripts. This gene set has previously been reported
based on established HIF target genes (36). In line with
this publication, the majority of these genes was found to
be hypoxically upregulated in PC3 shNTC control cells
(green dots in Figure 7A, left panel). Comparing
hypoxic expression levels of the same genes in PC3
shETV4 knock down with shNTC control cells, the
group of established HIF target genes roughly clustered
into two halves, representing transcripts which either
remained unaffected or which did not respond to
hypoxia anymore in the absence of ETV4 (Figure 7A,
right panel). Interestingly, following ranking of the HIF
target genes according to their requirement for ETV4,
the HIF-dependent PHD3 oxygen sensor (encoded by
EGLN3) showed the highest ETV4 sensitivity for
hypoxic induction in PC3 cells (Figure 7B and C),
demonstrating that ETV4 plays a major role in the
feedback control of mammalian oxygen sensing.
However, a number of established HIF-responsive genes
was only slightly affected (e.g. PAI1, encoded by
SERPINE1) or completely resistant (e.g. GLUT1,
Figure 5. Both HIF-1a and HIF-2a colocalize with ETV4 to the nucleus within molecular proximity. U2OS cells were transiently transfected with
the indicated CFP or YFP plasmids, and FRET analysis was performed at 20% O2 or 1% O2 24–48 h post-transfection. (A) Microscopic images
showing the subcellular localization of the exogenous proteins. Fluorescence intensity of FRET signals is visualized by false colors on a color bar
from low (blue) to high (white) intensity. (B) FRET efﬁciencies for CFP-ETV4 and YFP-HIF-1a (upper panel) or YFP-HIF-2a (lower panel) fusion
protein pairs were calculated from 20 to 40 randomly selected cells which displayed various ﬂuorescent acceptor/donor ratios. Scatter plots were ﬁt to
a single-site binding model. FRET efﬁciencies are given as the percentage of transferred energy relative to the energy absorbed by the donor.
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encoded by SLC2A1) to ETV4 depletion (see Figure 7B
and C), suggesting that the HIF pathway can be divided
into two branches according to the requirement for ETV4.
ETV4 expression levels correlate with HIF-a
accumulation in human breast cancer
Elevated ETV4 transcript levels have been reported in a
variety of human neoplastic diseases including breast
cancer (37). Moreover, the onset of spontaneous
mammary tumor development has been shown to be pro-
foundly delayed in MMTV-neu transgenic mice which
express a dominant negative variant of the mouse homo-
logue of ETV4, suggesting that ETV4 may possess tumor
promoting effects (38). We recently characterized protein
levels of a variety of hypoxic marker genes, including
HIF-1a, in tumor samples of 282 patients diagnosed
Figure 6. Genome-wide microarray expression analysis reveals a broad role for ETV4 in HIF mediated hypoxic gene regulation. (A) Efﬁcient knock
down of ETV4 in human PC3 prostate cancer cells. PC3 cells were stably transduced with lentiviral shRNA expression vectors encoding either a
nontarget control (shNTC) or shETV4. Following 24 h of exposure to 20% O2 or 0.2% O2, ETV4, HIF-1a, PHD2 and b-actin protein levels were
analyzed by immunoblotting. (B) Total RNA was isolated from cultures treated as in (A) and mRNA levels of ETV4 and its target gene COX2 were
determined by RT-qPCR. Gene expression levels were expressed in relation to ribosomal L28 mRNA (rel. levels) calculated from three independent
experiments. (C) Venn diagram showing the number of transcripts regulated by either an at least twofold induction by hypoxia alone (red), an at
least twofold reduction in normoxic cells by the knock down of ETV4 (green), or an at least twofold reduction in hypoxic cells by the knock down of
ETV4 (blue), respectively. (D) Heatmap of the individual expression levels of the 47 transcripts that required ETV4 for efﬁcient hypoxic induction.
(E) Expression levels of four randomly chosen transcripts shown in (D) were conﬁrmed by RT-qPCR as described for (B).
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Figure 7. Role of ETV4 in the regulation of established HIF target genes in vitro and in vivo. (A) Dot plots showing the correlation between
transcripts in normoxic versus hypoxic control cells (left panel) or in hypoxic control versus hypoxic ETV4 knock down cells (right panel) as derived
from the gene array data (grey dots). Red dots refer to internal controls and the blue dot shows ETV4 which is downregulated in shETV4 cells.
Green dots indicate the positions of a predeﬁned set of 61 well-established HIF target genes. (B) Heat map of the 61 HIF target genes ranked by the
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(continued)
with primary breast carcinoma (13,24). When the same
specimens were immunostained for ETV4 protein levels,
a strong and highly signiﬁcant correlation between ETV4
and PHD2 was observed in samples where both factors
were assessed (P< 0.01, Spearman’s rho, N=243).
Consistent with our model of synthetic action of ETV4
and HIF-a, a solid association was also observed
between these transcription factors and three well
described target genes (PAI1; GLUT1; CA9) of the HIF
pathway. Correlation coefﬁcients between ETV4, PHD2
and HIF-1a and HIF-2a were considerably higher than
those observed among both HIF-as and the three
markers for tissue hypoxia (Figure 7D and E),
demonstrating a putative role for ETV4 in the regulation
of PHD2 expression also in vivo.
DISCUSSION
Unique responsiveness to altered oxygen environments
and broad conservation of all components of the PHD/
HIF oxygen sensing pathway in multicellular life clearly
indicate the central role of HIFs as literally hypoxia-
inducible transcription factors (39). However, eukaryotic
gene expression is a multistep process requiring the
complex transcription machinery to interact with
promoter DNA and initiate transcription (40). Not sur-
prisingly, numerous studies have identiﬁed other nuclear
regulators that contribute to the full spectrum of tran-
scriptional changes in response to hypoxia. Yet, general
patterns of direct interplay among HIFs and other tran-
scriptional regulators are largely unknown and inter-
actions were often found to rely on speciﬁc cell models
(41). Here, we report on a novel screening approach that
in combination with overexpression of arrayed transcrip-
tion factors aimed for the systematic analysis of
HBS-speciﬁc transcription factor interplay. The core P2P
was used as a paradigm for HIF-dependent gene regula-
tion, as it embeds a single HBS conferring hypoxic activa-
tion and because the endogenous locus is ubiquitously
expressed.
We identiﬁed various members of the activating
protein-1 (AP-1) family as novel activators of the PHD2
gene, although JUN/FOS has been found to enhance
hypoxic gene expression previously (41). However, to the
best of our knowledge, our study is the ﬁrst to link ETV4
with HIF-dependent transcription. As shown by the use of
different reporter genes, ETV4 function as facilitator of
HIF-1 transactivation activity is not restricted to the P2P.
While nuclear distances between ETV4 and HIF-1/2a, as
calculated by FRET experiments, support a close
interaction, our data favor a model where p300/CBP
serves as essential bridging molecule between the two
factors. This conclusion is based on the following
features of the interaction between ETV4 and HIF-1a:
(i) oxygen sensitivity in the absence of the
oxygen-dependent degradation domain; (ii) mapping to
the C-terminal activation domain; (iii) competition by
CITED2; and (iv) requirement of FIH for oxygen sensi-
tivity. Such a ternary complex is still in line with the
FRET data, as previous ﬁndings suggest binding of
HIF-1a to both CH1 and CH3 domains of p300 (42).
ETV4 is known to interact with p300 at its CH3 domain
and, thus, might well get into close or even physical
contact to HIF-1a (43). Interestingly, out of 371 known
interactors of human p300/CBP (44), 101 (27.2%) were
present in the synthetic transactivation screen, but only
10 (9.9%) of them met the criteria to be considered as
reproducible activators of the P2P. Apparently, there is
no simple redundancy among the p300/CBP interactors
to serve as transcriptional coactivators, and the target
gene context is thought to play an important role in
p300/CBP complex formation (44). The latter is of par-
ticular importance, as it provides some reliability regard-
ing the speciﬁcity of our screening approach, underlining
its general applicability.
Based on literature searches, ETV4 and HIF pathways
share several common target genes, including matrix
metalloproteases (MMP) 1, MMP-3, MMP-7, MMP-9,
iNOS and COX-2 (45–48). Hence, one might speculate
that the two factors directly cooperate at regulatory
elements of these genes, jointly boosting invasive pro-
perties of malignant cells. Notably, ETV4 and its close
relatives ETV1 and ETV5 are frequently overexpressed
in prostate cancer due to gene fusion with androgen-
responsive gene loci (49). Similarly, loss of the tumor sup-
pressor PTEN causes high normoxic expression levels of
HIF-1a, a key feature of invasive prostate cancers (50).
Recent studies using animal models propose a mutational
sequence, where early loss of PTEN and overactivation of
ETS target genes collectively promote prostatic cancer
progression (34,51). Thus, it will be highly interesting to
explore a putative synthetic HIF-1/ETV4 role in these
pathologies.
Due to its high endogenous expression levels in the PC3
prostate cancer cell line, gene array analyses in ETV4
wild-type and knock down PC3 cells were undertaken to
explore the general role of ETV4 in hypoxic gene regula-
tion. Remarkably, 47 of 608 hypoxically induced tran-
scripts depend on ETV4 for efﬁcient upregulation.
Further analysis concentrating on a set of 61 established
Figure 7. Continued
magnitude of ETV4 requirement for hypoxic induction according to differences in hypoxic expression levels with hyp= log2(shNTC_hypoxia) 
log2(shETV4_hypoxia) and mean hypoxic expression levels centered to the mean of normoxic control cells. (C) Exemplary mRNA levels of HIF
target genes which either require ETV4 for efﬁcient hypoxic induction (PHD3 and CA9) or which remain unaffected by the ETV4 knock down
(GLUT1 and PAI1). mRNA was quantiﬁed as described for Figure 6B. (D and E) Correlation between ETV4 and established markers for tissue
hypoxia in human breast cancer. (D) Independent specimens (spec.) of immunohistochemical evaluation of ETV4 expression in primary mammary
carcinoma with high (upper panel) or low (lower panel) ETV4 expression levels. (E) Rank-order correlations (Spearman’s rho) for ETV4 and PHD2
as well as known markers reﬂecting tissue hypoxia (HIF-1a, HIF-2a, PAI1, GLUT1 and CA9) are summarized in a cross table. The number of cases
where both of the correlated markers could be assessed is displayed in parentheses. Asterisks indicate statistical signiﬁcance with *P< 0.05 and
**P< 0.01.
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HIF target genes revealed 14 genes whose hypoxic induc-
tion was at least twofold higher in the presence of ETV4
than in its absence. For example, hypoxic induction of
carbonic anhydrase 9 (CA9) was strongly dependent on
the presence of ETV4, as it was largely absent in ETV4
knock down cells. This ﬁnding further explains the un-
usually strong hypoxic inducibility of CA9 which has pre-
viously been attributed to the cooperation between HIF
and ATF-4 (52), another transcription factor that we
found to be involved in oxygen signaling (53). Somewhat
unexpected, PHD2 did not fulﬁl, at least in PC3 cells, our
stringency criteria for ETV4-dependent hypoxically
induced genes. Individual inspection revealed a 2.7-fold
hypoxic induction that was only reduced by 16% in the
absence of ETV4. Low hypoxic inducibility in this
cell type was also seen on the protein level (see also
Figure 6A) and might explain the rather weak response
of this gene to ETV4 depletion, despite the fact that forced
expression of ETV4 strongly induced the P2P in the U2OS
cell model. However, out of 61 established HIF target
genes, PHD3 was most sensitive to ETV4 depletion, sug-
gesting that in PC3 cells PHD3 rather than PHD2 might
represent the primary oxygen sensor targeted by ETV4.
In vivo, ETV4 has been implicated in kidney branching
morphogenesis, differentiation of spinal motor neurons
and mammary gland development (54–57). Importantly,
ETV1 (ER81), ETV4 (PEA3/E1AF) and ETV5 (ERM)
are highly similar and constitute the PEA3 subfamily
among the ETS-domain family of transcription factors
(58). ETV4 and ETV5 are functionally highly redundant
and a double knock out was required to reveal the role of
ETV4 in kidney development (54,55). Thus, we tested the
ability of these additional subfamily members to induce
the P2P. While ETV1 did not have any effect, ETV4 and
ETV5 super-induced the hypoxic PHD2 and transferrin
promoters in a HBS-dependent manner, suggesting func-
tional redundancy of these two subfamily members in hyp-
oxic gene regulation (Supplementary Figure S1). As the
DNA-binding/ETS domain is highly conserved between
all three PEA3 subfamily members, we further conclude
that the interaction with HIFa takes place outside of the
ETS domain of ETV4.
Because these developmental processes often occur in
tissues with low oxygenation, our data point to a role
of tissue hypoxia in physiological ETV4/ETV5 function.
Similarly, high expression levels of ETV4 have been linked
to metastasis or bad prognosis in a variety of human
cancers (59). These clinical features are well-known for
hypoxic tumors expressing high levels of HIF-1 (60).
Supporting our screening results, we found a strikingly
good correlation between ETV4 and PHD2 protein
levels in breast cancer tissues, in line with a potentially
relevant function of ETV4 in hypoxic tissues in vivo.
In summary, synthetic transactivation screening as
exemplarily demonstrated for HIF-dependent gene ex-
pression proved to be a powerful tool to unravel novel
interactions among common signaling pathways.
The general setup of this method may be easily adapted
to study other transcriptional pathways. A multiplexed
single-well readout system predestines this approach for
extensive screening projects, including small molecule
library analyses and genome-wide gene silencing
approaches, where inter-well variances are technically dif-
ﬁcult to control.
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